| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Olds Donald serves as a Director at GRCE. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $838 at current prices.
The biggest single holding is GRCE (~$838) as Director. Net of sales, the recent Form 4 record there shows accumulation of 381 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | GRCE Grace Therapeutics, Inc. | Director | Buy | 381 | $2.05 | $781.05 | New | -0.5% | +27.2% |